Brain cancer prediction is emerging as a critical focus in pediatric oncology, particularly with the advent of advanced artificial intelligence tools.A groundbreaking study from Harvard has showcased an AI model that surpasses traditional methods by accurately predicting the relapse risk of pediatric gliomas using brain scans.